NorthWest Biotherapeutics Inc (NWBO)

[JFR161162]

I estimate a 30% chance of MAA approval in April and a 70% chance in May due to:

1- Political support from both major parties in the UK.

2- The UK's efforts to attract biopharmaceutical companies and investment for clinical trials following its departure from the EU in 2020.
UK has new programs for accelerated approvals & trials.
They can’t have delays at this point of time.
A decision is expected at the latest by the end of May, within 150 days.